Cancer clinical trials in the region Auvergne-Rhône-Alpes

256 currently recruiting clinical trials
Region Auvergne-Rhône-Alpes

Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized ALK None Systemic Treatment-Naive Surgery
Hoffmann-La Roche
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
ALK EGFR
Bristol-Myers Squibb
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
AstraZeneca
Phase 3 Breast cancer
#NCT05232916
HER2 Positive Localized Locally Advanced None Targeted therapy Targeted therapy
Systemic Treatment-Naive Systemic Treatment-Naive
Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Centre Léon Bérard (Lyon)
Greenwich LifeSciences, Inc.
Phase 3 Lung cancer
#NCT06472245
NSCLC (Non-Small Cell Lung Cancer) Metastatic Immunotherapy
ALK EGFR ROS-1
Hôpital de la Croix Rousse - Hospices Civils de Lyon (Lyon), Centre Hospitalier Universitaire de Grenoble (La Tronche)
OSE Immunotherapeutics
Phase 3 Lung cancer
#NCT06646276
SCLC (Small Cell Lung Cancer) Locally Advanced Metastatic None Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Hôpitaux Nord-Ouest - Villefranche-sur-Saône (Gleizé), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Bristol-Myers Squibb